LIVN 株価分析 — LIVANOVA PLC (Healthcare >> Medical Devices)
LIVN に関するよくある質問
LIVNのPER(株価収益率)は?
LIVANOVA PLC(LIVN)は現在PER 41.56倍で取引されています。
LIVNのROE(自己資本利益率)は?
LIVANOVA PLCのROEは8.84%です。
LIVNの配当利回りは?
LIVANOVA PLCの配当利回りは0.00%です。
LIVNの品質スコア(Quality Score)は?
当社のAIはLIVNの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
LIVNは今が買い時ですか?
当社AIのタイミングスコアは100点中89点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
LIVNはどのセクターに属しますか?
LIVANOVA PLCはHealthcare >> Medical Devicesセクターに分類されます(NASDAQ市場)
LIVN AI Analysis Summary
Our AI summary for LIVN: LIVANOVA PLC (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 41.56, ROE of 8.84%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 80.14
Price
-0.91
(-1.12%)
Day Change
|
|
|---|
LIVN, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) but テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 80.14 |
| PBV / Sector |
3.68 / -101.57
|
| Earning Per Share | 1.93 |
| PE / Sector |
41.56 / 31.23
|
| PEG or PE/Growth / Sector |
-0.36 / 0.40
|
| Average 1M Daily Value |
43.73 M
GREAT
|
| Average 1W Daily Value |
42.09 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:07 |
| Symbol | LIVN |
| Name | LIVANOVA PLC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 54.93 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 4,452.36 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 5220 Valiant Court, Gloucester, United Kingdom, GL3 4FE
Phone: 44 1452 638 500
Website: https://www.livanova.com
Employees: 3,300
Sector: Healthcare >> Medical Devices
Description: LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google